Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Patterson

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Medical Mycology|January 30, 2013
Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosisKalyani Jambunathan, Douglas S Watson, Laura K Najvar, et al.
BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisSofia Perea, José L López-Ribot, Brian L Wickes, et al.
Medical Mycology|January 30, 2010
Screening for drug-resistant Candida yeasts with chromogenic agarWilliam R Kirkpatrick, Joseph D Zimmerman, Fadi P Haikal, et al.
Plos One|December 22, 2021
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe diseaseRaphael A Reyes, Kathleen Clarke, S Jake Gonzales, et al.
Biorxiv : the Preprint Server for Biology|October 6, 2021
SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe diseaseRaphael A Reyes, Kathleen Clarke, S Jake Gonzales, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
International Journal of Molecular Sciences|February 8, 2012
Assessment of Aspergillus fumigatus in guinea pig bronchoalveolar lavages and pulmonary tissue by culture and realtime polymerase chain reaction studiesDennis G Hooper, Vincent E Bolton, John S Sutton, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2012
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosisWilliam R Kirkpatrick, Laura K Najvar, Ana C Vallor, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Medical Mycology|January 30, 2013
Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosisKalyani Jambunathan, Douglas S Watson, Laura K Najvar, et al.
BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisSofia Perea, José L López-Ribot, Brian L Wickes, et al.
Medical Mycology|January 30, 2010
Screening for drug-resistant Candida yeasts with chromogenic agarWilliam R Kirkpatrick, Joseph D Zimmerman, Fadi P Haikal, et al.
Plos One|December 22, 2021
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe diseaseRaphael A Reyes, Kathleen Clarke, S Jake Gonzales, et al.
Biorxiv : the Preprint Server for Biology|October 6, 2021
SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe diseaseRaphael A Reyes, Kathleen Clarke, S Jake Gonzales, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
International Journal of Molecular Sciences|February 8, 2012
Assessment of Aspergillus fumigatus in guinea pig bronchoalveolar lavages and pulmonary tissue by culture and realtime polymerase chain reaction studiesDennis G Hooper, Vincent E Bolton, John S Sutton, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2012
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosisWilliam R Kirkpatrick, Laura K Najvar, Ana C Vallor, et al.
Pageof 21